Plenary Abstracts Session & Oral Presentations
HemaSphere, Volume 9, Issue S1, June 2025.
wiley +1 more source
European reclassification of non-invasive brain stimulation as class III medical devices: A call to action. [PDF]
Baeken C +11 more
europepmc +1 more source
Update on the Brussels IIa Recast Regulation
In the essay, we will first briefly review the scope of the Recast (I), then address the innovations introduced since the Regulation Brussels IIa (II) and, finally, discuss the points on which the Recast remains silent (III).
openaire +1 more source
Early and accelerated access programs for medical devices in the European Union: mapping regulatory derogations and national schemes. [PDF]
Haon B +4 more
europepmc +1 more source
Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine. [PDF]
Liu G +8 more
europepmc +1 more source
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy. [PDF]
Bouchart C +22 more
europepmc +1 more source
Diagnostic Performance of Commercial Antithrombin Activity Assays: Do We Get What We Expect? [PDF]
Orlando C +4 more
europepmc +1 more source
A roadmap for supporting the development of advanced therapy medicinal products in a European framework. [PDF]
Van Eldere J +25 more
europepmc +1 more source
Classification grid and evidence matrix for evaluating digital medical devices under the European union landscape. [PDF]
Boers M +14 more
europepmc +1 more source

